SEGMENT INFORMATION

9 Months Ended

Dec. 28, 2013

Segment Reporting [Abstract]

SEGMENT INFORMATION

SEGMENT INFORMATION

Segment Definition Criteria

We manage our business on the basis of one operating segment: the design, manufacture, and marketing of blood management solutions. Our chief operating decision-maker uses consolidated results to make operating and strategic decisions. Manufacturing processes, as well as the regulatory environment in which we operate, are largely the same for all product categories.

Enterprise-Wide Disclosures about Product and Services

We have four global product families: plasma, blood center, hospital, and software solutions.

Our products include whole blood disposables, equipment devices and the related disposables used with these devices. Disposables include part of plasma, blood center, and hospital product families. Plasma consists of the disposables used to perform apheresis for the separation of whole blood components and subsequent collection of plasma to be used as a raw material for biologically derived pharmaceuticals. Blood center consists of disposables which separate whole blood for the subsequent collection of platelets, plasma, red cells, or a combination of these components for transfusion to patients as well as disposables for manual whole blood collection. Hospital consists of surgical disposables (principally the Cell Saver^® autologous blood recovery system targeted to procedures that involve rapid, high volume blood loss such as cardiovascular surgeries and the cardioPAT^® cardiovascular perioperative autotransfusion system designed to remain with the patient following surgery to recover blood and the patient’s red cells to prepare them for reinfusion), the OrthoPAT^® orthopedic perioperative autotransfusion system designed to operate both during and after surgery to recover and wash the patient’s red cells to prepare them for reinfusion, and diagnostics products (principally the TEG^® Thrombelastograph^® hemostasis analyzer used to help assess a surgical patient’s hemostasis during and after surgery). Software solutions include information technology platforms that assist blood centers, plasma centers, and hospitals to more effectively manage regulatory compliance and operational efficiency.

Revenues from External Customers:

	Three Months Ended
(In thousands)	December 28, 2013		December 29, 2012
Disposable revenues
Plasma disposables	$	76,698	$	68,102
Blood center disposables
Platelet	43,447		45,139
Red cell	9,869		11,752
Whole blood	47,342		54,894
	100,658		111,785
Hospital disposables
Surgical	16,807		18,900
OrthoPAT	6,392		7,090
Diagnostics	8,565		6,761
	31,764		32,751
Total disposables revenue	209,120		212,638
Software solutions	17,603		16,008
Equipment & other	15,397		18,749
Net revenues	$	242,120	$	247,395

	Nine Months Ended
(In thousands)	December 28, 2013		December 29, 2012
Disposable revenues
Plasma disposables	$	217,768	$	200,657
Blood center disposables
Platelet	117,778		125,579
Red cell	30,098		35,738
Whole blood	145,879		83,514
	293,755		244,831
Hospital disposables
Surgical	49,247		55,965
OrthoPAT	18,973		22,276
Diagnostics	24,144		20,196
	92,364		98,437
Total disposables revenue	603,887		543,925
Software solutions	51,469		51,354
Equipment & other	42,062		46,769
Net revenues	$	697,418	$	642,048